MELISSA REZK: Open Payments
NPI 1114411477 · WERNERSVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$356 in 18 payments from 10 companies in 2025. Trend: 2023 $560 · 2024 $754 · 2025 $356
Food & beverage: $356
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $87 |
| Dexcom, Inc. | 2 | $50 |
| BETA BIONICS, INC. | 2 | $34 |
| Lilly USA, LLC | 2 | $34 |
| KYOWA KIRIN, INC. | 1 | $29 |
| Xeris Pharmaceuticals, Inc. | 2 | $29 |
| Abbott Laboratories | 1 | $28 |
| Sequel Med Tech, LLC | 1 | $27 |
| Insulet Corporation | 1 | $19 |
| Amphastar Pharmaceuticals, Inc. | 1 | $19 |
Products named: Wegovy, Dexcom G6 Transmitter, iLet Bionic Pancreas, MOUNJARO, Ozempic, CRYSVITA, GVOKE HYPOPEN, FREESTYLE LIBRE 3.
Industry payments across PA — which companies pay providers there.
